Home › Myotonic Dystrophy › Florida
Myotonic Dystrophy clinical trials in Florida
3 studies for Myotonic Dystrophy are looking for participants at sites in Florida.
Cities in Florida
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- University of Florida, 2004 Mowry Road - Site Number: 8400005, Gainesville
- University of South Florida - Neuromuscular Research, 13330 USF Laurel Drive - Site Number: 8400001, Tampa
RecruitingPhase 1/2
Ages 10 to 55 · All sexes · Updated Sep 21, 2026 · NCT06844214Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- University of Florida, Gainesville
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 10, 2026 · NCT03981575Study of ATX-01 in Participants With DM1
- University of Florida, Gainesville
RecruitingPhase 1/2
Ages 18 to 64 · All sexes · Updated Feb 10, 2026 · NCT06300307From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.